Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Short Interest Update

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) was the recipient of a large growth in short interest in January. As of January 30th, there was short interest totaling 172,947 shares, a growth of 19.9% from the January 15th total of 144,184 shares. Based on an average daily trading volume, of 68,792 shares, the days-to-cover ratio is presently 2.5 days. Based on an average daily trading volume, of 68,792 shares, the days-to-cover ratio is presently 2.5 days.

Wall Street Analysts Forecast Growth

NTHI has been the topic of a number of research reports. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Neonc Technologies Price Performance

Shares of NASDAQ NTHI traded down $0.45 during mid-day trading on Wednesday, hitting $8.81. 41,892 shares of the company were exchanged, compared to its average volume of 66,840. Neonc Technologies has a 1-year low of $3.20 and a 1-year high of $25.00. The stock has a 50 day simple moving average of $9.10 and a 200-day simple moving average of $8.87.

Insider Transactions at Neonc Technologies

In other news, President Amir F. Heshmatpour bought 6,000 shares of Neonc Technologies stock in a transaction on Monday, November 24th. The stock was acquired at an average price of $6.51 per share, with a total value of $39,060.00. Following the completion of the acquisition, the president directly owned 2,992,000 shares of the company’s stock, valued at $19,477,920. The trade was a 0.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders bought 31,100 shares of company stock valued at $192,099.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. 683 Capital Management LLC acquired a new stake in Neonc Technologies in the fourth quarter valued at $442,000. OMERS ADMINISTRATION Corp purchased a new position in shares of Neonc Technologies in the 4th quarter valued at about $126,000. Barclays PLC lifted its stake in shares of Neonc Technologies by 5,314.8% in the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after purchasing an additional 8,982 shares during the period. State Street Corp boosted its holdings in Neonc Technologies by 9.9% during the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after buying an additional 3,900 shares in the last quarter. Finally, Goldman Sachs Group Inc. purchased a new position in Neonc Technologies in the fourth quarter valued at about $124,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.